Noninvasive Ventilation in an Intermediate-Care-Unit

Detalhes bibliográficos
Autor(a) principal: Felgueiras, Joana
Data de Publicação: 2006
Outros Autores: Lohmann, Corinna, Delerue, Francisca, Barata, José
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://revista.spmi.pt/index.php/rpmi/article/view/1628
Resumo: Background: Non-Invasive Ventilation (NIV) is a method of alveolar ventilation, which has been shown to be effi cient and safe in patients with chronic or acute respiratory insuffi ciency. Our experience with NIV, in a Medical Intermediate-Care-Unit, over a 2-year period, is presented.Methods: A retrospective study of 66 patients who were treated with NIV, in the medical intermediate care unit (MICU) of the Garcia de Orta Hospital, between January of 2001 and December 2002 was performed. Epidemiological, clinical and laboratory data were analysed.Results: Of 315 patients admitted to the MICU, 66 (20%) were ventilated non-invasively. Fifty-three percent were male and the mean age was 68 years. The main underlying conditions leading to NIV were Chronic Obstructive Pulmonary Disease (COPD) in 33 patients (50%), Pneumonia in 12 (18%), Congestive Heart Failure (CHF) in 9 (14%), Post-Extubation-Syndrome (PES) in 6 (9%), Pickwick Disease in 4 (6%), Kyphoscoliosis and Amyotrophic Lateral Sclerosis (ALS) one of each. The interface most commonly selected for NVI was the face mask (98%). After 48 hours of ventilation, signifi cant improvement of gas exchange was achieved in 61% of patients. Nine patients deteriorated clinically within this period, of whom, three needed to be transferred to an intensive care unit for invasive ventilation and 3 patients died. The mean length of stay in the MICU was 8.5 days, with a mean time of ventilation of 6.4 days ( 8.8 in CHF, 7 in PES, 6 in COPD and 3.8 in Pneumonia). Invasive ventilation was necessary in 11 patients, 4 with COPD, 3 with pneumonia, 2 with CHF, 1 with Pickwick disease and 1 with PES. Nine percent of the patients, all suffering from COPD, continued NIV after discharge on an outpatient basis. The overall mortality of patients undergoing NIV was 21%.Conclusion and Discussion: NIV lead to signifi cant improvement in gas exchange in 61% of patients, within the fi rst 48 hours. Patients with COPD, CHF and pneumonia had the highest benefi t, the latter requiring the shortest time of ventilation.
id RCAP_a359e5eaa2ec32b28a747b329b5ea0c0
oai_identifier_str oai:oai.revista.spmi.pt:article/1628
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Noninvasive Ventilation in an Intermediate-Care-UnitVentilação Não Invasiva numa Unidade de Cuidados IntermédiosVentilação não invasivaunidade cuidados intermédiosdoença pulmonar obstrutiva crónicanon invasive ventilationintermediate care unitchronic obstructive pulmonary diseaseBackground: Non-Invasive Ventilation (NIV) is a method of alveolar ventilation, which has been shown to be effi cient and safe in patients with chronic or acute respiratory insuffi ciency. Our experience with NIV, in a Medical Intermediate-Care-Unit, over a 2-year period, is presented.Methods: A retrospective study of 66 patients who were treated with NIV, in the medical intermediate care unit (MICU) of the Garcia de Orta Hospital, between January of 2001 and December 2002 was performed. Epidemiological, clinical and laboratory data were analysed.Results: Of 315 patients admitted to the MICU, 66 (20%) were ventilated non-invasively. Fifty-three percent were male and the mean age was 68 years. The main underlying conditions leading to NIV were Chronic Obstructive Pulmonary Disease (COPD) in 33 patients (50%), Pneumonia in 12 (18%), Congestive Heart Failure (CHF) in 9 (14%), Post-Extubation-Syndrome (PES) in 6 (9%), Pickwick Disease in 4 (6%), Kyphoscoliosis and Amyotrophic Lateral Sclerosis (ALS) one of each. The interface most commonly selected for NVI was the face mask (98%). After 48 hours of ventilation, signifi cant improvement of gas exchange was achieved in 61% of patients. Nine patients deteriorated clinically within this period, of whom, three needed to be transferred to an intensive care unit for invasive ventilation and 3 patients died. The mean length of stay in the MICU was 8.5 days, with a mean time of ventilation of 6.4 days ( 8.8 in CHF, 7 in PES, 6 in COPD and 3.8 in Pneumonia). Invasive ventilation was necessary in 11 patients, 4 with COPD, 3 with pneumonia, 2 with CHF, 1 with Pickwick disease and 1 with PES. Nine percent of the patients, all suffering from COPD, continued NIV after discharge on an outpatient basis. The overall mortality of patients undergoing NIV was 21%.Conclusion and Discussion: NIV lead to signifi cant improvement in gas exchange in 61% of patients, within the fi rst 48 hours. Patients with COPD, CHF and pneumonia had the highest benefi t, the latter requiring the shortest time of ventilation.A ventilação não invasiva (VNI) é um modo de ventilação mecânica alveolar, que tem sido utilizada de forma crescente em situações de insuficiência respiratória aguda e crónica agudizada. Objectivo: Demonstrar a experiência com a VNI, numa Unidade de Cuidados Intermédios durante 2 anos.Métodos: Foram analisados retrospectivamente dados epidemiológicos, clínicos e laboratoriais de 66 doentes, submetidos a VNI, admitidos entre Janeiro de 2001 e Dezembro de 2002, numa unidade de cuidados intermédios - Unidade Médica Diferenciada (UMD), do Hospital Garcia de Orta (HGO).Resultados: Em 315 doentes internados na UMD, 66 (20%) foram ventilados não invasivamente. A maioria era do sexo masculino (53%), com idade média de 68 anos. As patologias, que motivaram a VNI, foram a Doença Pulmonar Obstrutiva Crónica (DPOC) agudizada em 33 doentes (50%), a Pneumonia em 12 (18%), a Insuficiência Cardíaca (IC) em 9 (14%), a Síndrome Pós-Extubação (SPE) em 6 (9%), a Síndrome de Pickwick em 4 (6%) e a Cifoescoliose e a Esclerose Lateral Amiotrófica (ELA) num doente cada. O tipo de interface doente/ventilador mais utilizado foi a máscara facial (98%). Às 48 horas de ventilação, verificou-se melhoria das trocas gasosas em 40 doentes (61%) e agravamento em 9, dos quais, 3 necessitaram de ventilação invasiva, e outros 3 faleceram. Os doentes estiveram ventilados numa média de 6.4 dias, 10 na síndrome de Pickwick, 8.8 na IC, 7 na SPE, 6 na DPOC e 3.8 na pneumonia; com um tempo médio de internamento na UMD de 8.5 dias. Houve necessidade de ventilação invasiva em 11 doentes, 4 doentes com DPOC, 3 com pneumonia, 2 com IC, 1 com síndrome Pickwick e 1 com SPE. Tiveram alta com indicação para manter VNI em ambulatório 9% dos doentes, todos com DPOC. A taxa de mortalidade foi de 21%.Conclusão e Discussão: A VNI demonstrou ser eficaz com melhoria gasimétrica em 61 % dos doentes às 48 horas. O maior benefício verificou-se nos doentes com DPOC, com insuficiência cardíaca e com pneumonia, estes últimos com um número reduzido de dias de ventilação.Sociedade Portuguesa de Medicina Interna2006-06-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://revista.spmi.pt/index.php/rpmi/article/view/1628Internal Medicine; Vol. 13 No. 2 (2006): Abril/ Junho; 73-78Medicina Interna; Vol. 13 N.º 2 (2006): Abril/ Junho; 73-782183-99800872-671Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revista.spmi.pt/index.php/rpmi/article/view/1628https://revista.spmi.pt/index.php/rpmi/article/view/1628/1095Felgueiras, JoanaLohmann, CorinnaDelerue, FranciscaBarata, Joséinfo:eu-repo/semantics/openAccess2023-02-25T06:11:03Zoai:oai.revista.spmi.pt:article/1628Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:47:16.662309Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Noninvasive Ventilation in an Intermediate-Care-Unit
Ventilação Não Invasiva numa Unidade de Cuidados Intermédios
title Noninvasive Ventilation in an Intermediate-Care-Unit
spellingShingle Noninvasive Ventilation in an Intermediate-Care-Unit
Felgueiras, Joana
Ventilação não invasiva
unidade cuidados intermédios
doença pulmonar obstrutiva crónica
non invasive ventilation
intermediate care unit
chronic obstructive pulmonary disease
title_short Noninvasive Ventilation in an Intermediate-Care-Unit
title_full Noninvasive Ventilation in an Intermediate-Care-Unit
title_fullStr Noninvasive Ventilation in an Intermediate-Care-Unit
title_full_unstemmed Noninvasive Ventilation in an Intermediate-Care-Unit
title_sort Noninvasive Ventilation in an Intermediate-Care-Unit
author Felgueiras, Joana
author_facet Felgueiras, Joana
Lohmann, Corinna
Delerue, Francisca
Barata, José
author_role author
author2 Lohmann, Corinna
Delerue, Francisca
Barata, José
author2_role author
author
author
dc.contributor.author.fl_str_mv Felgueiras, Joana
Lohmann, Corinna
Delerue, Francisca
Barata, José
dc.subject.por.fl_str_mv Ventilação não invasiva
unidade cuidados intermédios
doença pulmonar obstrutiva crónica
non invasive ventilation
intermediate care unit
chronic obstructive pulmonary disease
topic Ventilação não invasiva
unidade cuidados intermédios
doença pulmonar obstrutiva crónica
non invasive ventilation
intermediate care unit
chronic obstructive pulmonary disease
description Background: Non-Invasive Ventilation (NIV) is a method of alveolar ventilation, which has been shown to be effi cient and safe in patients with chronic or acute respiratory insuffi ciency. Our experience with NIV, in a Medical Intermediate-Care-Unit, over a 2-year period, is presented.Methods: A retrospective study of 66 patients who were treated with NIV, in the medical intermediate care unit (MICU) of the Garcia de Orta Hospital, between January of 2001 and December 2002 was performed. Epidemiological, clinical and laboratory data were analysed.Results: Of 315 patients admitted to the MICU, 66 (20%) were ventilated non-invasively. Fifty-three percent were male and the mean age was 68 years. The main underlying conditions leading to NIV were Chronic Obstructive Pulmonary Disease (COPD) in 33 patients (50%), Pneumonia in 12 (18%), Congestive Heart Failure (CHF) in 9 (14%), Post-Extubation-Syndrome (PES) in 6 (9%), Pickwick Disease in 4 (6%), Kyphoscoliosis and Amyotrophic Lateral Sclerosis (ALS) one of each. The interface most commonly selected for NVI was the face mask (98%). After 48 hours of ventilation, signifi cant improvement of gas exchange was achieved in 61% of patients. Nine patients deteriorated clinically within this period, of whom, three needed to be transferred to an intensive care unit for invasive ventilation and 3 patients died. The mean length of stay in the MICU was 8.5 days, with a mean time of ventilation of 6.4 days ( 8.8 in CHF, 7 in PES, 6 in COPD and 3.8 in Pneumonia). Invasive ventilation was necessary in 11 patients, 4 with COPD, 3 with pneumonia, 2 with CHF, 1 with Pickwick disease and 1 with PES. Nine percent of the patients, all suffering from COPD, continued NIV after discharge on an outpatient basis. The overall mortality of patients undergoing NIV was 21%.Conclusion and Discussion: NIV lead to signifi cant improvement in gas exchange in 61% of patients, within the fi rst 48 hours. Patients with COPD, CHF and pneumonia had the highest benefi t, the latter requiring the shortest time of ventilation.
publishDate 2006
dc.date.none.fl_str_mv 2006-06-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revista.spmi.pt/index.php/rpmi/article/view/1628
url https://revista.spmi.pt/index.php/rpmi/article/view/1628
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revista.spmi.pt/index.php/rpmi/article/view/1628
https://revista.spmi.pt/index.php/rpmi/article/view/1628/1095
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Medicina Interna
publisher.none.fl_str_mv Sociedade Portuguesa de Medicina Interna
dc.source.none.fl_str_mv Internal Medicine; Vol. 13 No. 2 (2006): Abril/ Junho; 73-78
Medicina Interna; Vol. 13 N.º 2 (2006): Abril/ Junho; 73-78
2183-9980
0872-671X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1817552902561988608